Co’s Hong Kong IPO, as the company targets a HK$13.19bn ($1.69bn) valuation. Mainland-based MicroTech manufactures medical devices for diabetes management. Founded in 2011, the company began selling …
( read original story …)
The HongKong News
Co’s Hong Kong IPO, as the company targets a HK$13.19bn ($1.69bn) valuation. Mainland-based MicroTech manufactures medical devices for diabetes management. Founded in 2011, the company began selling …
( read original story …)